Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KLA Corp. (KLAC) vs Koninklijke Philips NV (PHG) Price & Performance

Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

KLA Corp. vs Koninklijke Philips NV — how do they compare? KLA Corp. trades at $203.16 (market cap $251.82B), while Koninklijke Philips NV trades at $27.09 (market cap $26.33B). The key difference: KLA Corp. is far larger — about 9.6× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.76%). Which is the better fit depends on your goals.

KLACPHG
Market Cap
$251.82B$26.33B
Sector
TechnologyHealth
52-Week High
$301.71$32.91
52-Week Low
$84.39$25.02
Enterprise Value
$253.07B$32.89B
Dividend Yield
0.48%3.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KLA Corp.

KLA Corporation (KLAC) trades at $198.11, up 2.53% today, with a neutral technical signal despite bullish moving averages. The stock shows strong fundamentals, including a 35.57% net income margin and consistent earnings beats, with Q3 2026 EPS expected at $1.17. Recent corporate actions include a 1:10 stock split and a $2.30 dividend, while cash flow remains positive at $101.78M in 2025. Analyst sentiment is optimistic, with a $246.93 consensus price target implying significant upside.

The outlook for KLAC is positive, driven by AI-driven semiconductor demand and robust profitability, but risks include high valuation multiples and market volatility. Investment opportunities center on growth in advanced packaging, with Wall Street largely bullish; however, investors should monitor competitive pressures and economic cycles that could impact the chip equipment sector.

Koninklijke Philips NV

PHG trades at $26.73, up 1.52% today, with a bullish technical signal and recent earnings beats in Q4 2025, Q1 2026, and Q2 2026. The company reported $17.83B revenue and $895M net income for 2025, with a P/E of 20.29 and net margin of 6.31%. Recent news highlights Exor increasing its stake and FDA clearances for new health tech products, supporting positive sentiment.

Outlook is cautiously optimistic with strong profitability and institutional interest, but risks include order intake volatility and debt levels. Analysts show 40.9% buy ratings, indicating potential upside if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KLA Corp.

KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.

Read more on KLAC

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG